2009. Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: clinical activity and molecular markers. Hematology Meeting Reports (formerly Haematologica Reports). 2, 13 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i13.482.